Literature DB >> 21961090

Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved.

Stephen M Barratt1, John S Leeds, David S Sanders.   

Abstract

BACKGROUND: Coeliac Disease (CD) is an increasingly common autoimmune condition, the treatment of which is a gluten-free diet (GFD). Previous studies fail to reach consensus of the impact this restrictive diet has on an individual's quality of life (QoL). Furthermore, how patient characteristics, such as demographic and educational background, may predict GFD adherence is poorly understood. We aimed to assess which factors had an impact on Qol in patients with CD.
METHODS: Case-control postal survey (n=573). Biopsy-proven CD patients (n=225; mean disease duration 8yrs; range 0.5-52yrs; male 26%) and age and sex matched controls (n=348; male 36%) completed The Short-Form 36-Item (SF-36) QoL measure, The Hospital Anxiety & Depression Scale (HADS), GFD assessment, and demographic questionnaire.
RESULTS: We found a high proportion of GFD adherence: 'Full Adherence' 65%, 'Partial Adherence' 31%, 'None Adherence' 4%, accompanied however, by 80% of patients reporting difficulty adhering to the GFD: 'Impossible' 5%, 'Mostly difficult' 14%, 'Sometimes difficult' 61%, 'No difficulty' 20%. Negligible differences in QoL scores were observed when comparing full versus partial/none GFD patients (P=>0.05), however, stepwise reductions in QoL and increasing likelihood of anxiety/depression were found in association with increasing degree of difficulty adhering to the GFD (P=<0.0001). Demographic assessment suggests that an affluent background and a university education promote greater GFD adherence.
CONCLUSIONS: Most coeliac patients adhere to a GFD but encounter difficulty doing so (potentially influenced by social and educational background). The degree of GFD difficulty is associated with reductions in patient wellbeing and psychological distress that the dietician is critically placed to address.

Entities:  

Mesh:

Year:  2011        PMID: 21961090

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  41 in total

1.  Adherence to gluten-free diet and barriers to adherence in patients with celiac disease.

Authors:  Preeti Rajpoot; Aishwairya Sharma; S Harikrishnan; Bhaskar J Baruah; Vineet Ahuja; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2015-11-18

2.  Detection of Gluten in Gluten-Free Labeled Restaurant Food: Analysis of Crowd-Sourced Data.

Authors:  Benjamin A Lerner; Lynn T Phan Vo; Shireen Yates; Andrew G Rundle; Peter H R Green; Benjamin Lebwohl
Journal:  Am J Gastroenterol       Date:  2019-05       Impact factor: 10.864

3.  Celiac disease: a challenging disease for pharmaceutical scientists.

Authors:  Simon Matoori; Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2012-12-11       Impact factor: 4.200

Review 4.  Current Status of Celiac Disease Drug Development.

Authors:  Manida Wungjiranirun; Ciaran P Kelly; Daniel A Leffler
Journal:  Am J Gastroenterol       Date:  2016-03-29       Impact factor: 10.864

Review 5.  Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.

Authors:  Celia Escudero-Hernández; Amado Salvador Peña; David Bernardo
Journal:  Curr Gastroenterol Rep       Date:  2016-07

6.  Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.

Authors:  Daniel A Leffler; Ciaran P Kelly; Peter H R Green; Richard N Fedorak; Anthony DiMarino; Wendy Perrow; Henrik Rasmussen; Chao Wang; Premysl Bercik; Natalie M Bachir; Joseph A Murray
Journal:  Gastroenterology       Date:  2015-02-13       Impact factor: 22.682

7.  Hypervigilance to a Gluten-Free Diet and Decreased Quality of Life in Teenagers and Adults with Celiac Disease.

Authors:  Randi L Wolf; Benjamin Lebwohl; Anne R Lee; Patricia Zybert; Norelle R Reilly; Jennifer Cadenhead; Chelsea Amengual; Peter H R Green
Journal:  Dig Dis Sci       Date:  2018-01-31       Impact factor: 3.199

Review 8.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

Review 9.  Psychological morbidity of celiac disease: A review of the literature.

Authors:  Fabiana Zingone; Gillian L Swift; Timothy R Card; David S Sanders; Jonas F Ludvigsson; Julio C Bai
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 10.  Support for patients with celiac disease: A literature review.

Authors:  Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.